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Sttturosporinc. :m antibiotic known to inhibit cellular protein kinrscs. cun rcvarsibly bltsk the progrcrs ofnorn~al and tumour ccllr into the cell 
cpclc. The ability of HIV-I to infect and rcplicalc in cells blocked by rtuurorprinc was invcstigatcd. The results show thnt blocked. non-cycling 
ccllr cun bc productively infected by HIY.1, stc;rdily releasing infectious progeny virus far rcvcr~l weckr. This suggests that ut km in some cum, 
HIV-I can TV found in u stable and artivc stats in rcstiqt. non-prdikmting 7 ocllr. 
Protein kinarc inhibitor; Yirtll infectivity; Cc’1 cycle T ocll 
1. INTRODUCTION 
Most retroviruscs rcquirc that the newly infected cells 
undergo at lcust one round of DNA rcpliwtion and 
mitosis for the synthesis of new virus to begin [l], It is 
gcncrrrlly accepted that non-dividing T-lytnphorytcs 
cannot bc productively infected by HIV-l, P rctrovirus 
implicutcd in the uctiology of AIDS: only the untigcn- 
or mitogcn-ustivatcd ones can be [2]. Infection of non- 
activated T-lymphosytss Itads to incomplcrc rcvex 
transcription of’ HfS-RNA [3,4]. Furthermore, it has 
been shown that blocking the activation of lymphocytes 
by prc-incubation with cyclosporinc A prevents them 
from being productively infected by HIV-I [S]. 
It has been reported that binding of HIV-1 to CD4 
rcccptor induces rapid phosphorylation of the receptor. 
Such phosphoryli~tion. mcdintcd by a protein kinasc C, 
can be sclcctivcly inhibited by specific ompounds, rc- 
suiting in nn accumulation of virus particles at the ccl1 
surface irnd inhibiting HIV infectivity at the same time 
[6]. Other studies hme shown that protein kinnsc C 
inhibitors can exert an inhibitory effxt on the entry ilzd 
infectivity of several enveloped viruses [7]. 
Since staurosporinc isa gcnernl protein kinusc inhib- 
itor, known to arrest non-transformed cells in both GI 
and Gz phases of the cell cycle snd transformed cells in 
the G2 phase [8,9], it was worth investigating its effect 
Abhrcviuliurls: DMSO.dimcthyl sulfoxidc; HIV-I. humttn immunodc- 
ficicncy virus typz I; IF. immunolluorcsccnce: Mub. mon~lonrtlnnti- 
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sue cuhurc medium. 
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on the ability of HIV to productively infect cell lines 
blocked by the prcscncc of this antibiotic in the tissue 
culture medium. 
2. MATERIAL§ AND METHODS 
Three human cell lines: HUT-78, u tumour T-cell line nlso known 
ah MY: HS&, an irnmttturc T-cell line; and tDW7, a mixed T/3 ccl1 
lk wcrc used as target cclls.Thcy wcrcculturcd in TCM: RPMI-I&O 
medium supptcmcnlcd wilb 5% newborn calf serum without nntibiot- 
its, :hnd kept at 37.C in n 5% CD, atmorphcrc. The IW-l virus $trttin 
ussd for the prcssnt study WBL HTLY-BIB [IO]. The virus was Crown 
in cultures of lDW7 tills. Supcrnrtants of infected c~tltum wcrc 
clwrcd from ccllr by ccntrifugnrion and fillralion through 0.45 pm 
Milliporc nrcmbranos. Such supcrnulantswcre directly used for caper- 
imcntul infection offrcrh cells. Thcumount ofvirus prcssnr in infected 
culture supcrnutanls was dctcnirincd in triplicates using un ELlSA kit 
spccilic for p?4 mujor core virnl protein (DuPont NEK-O4S, ~34 
cut.ulX 6 pgml). Usually the infectious supcrnalunts hnd p24 coneen- 
trations ritnging from 0.4 lo 10 ng/ml, 
For viral infection, the tilrgct cells wcrc resuspended in cnll-frco 
infectious supsrnatnnt. nt tt ratio of 1x10* ocllulml. and incubrrtod Irt 
37.C for 3 h. The viral inoculurn wus rcmovod by ccntrifugntion at 
250~~ and llir cell psllct wus rcsuspctrdcd in PBS and further washed 
twice in PBS. The final cell pcllcts were rcauspcndcd in TCM nnd 
truns:‘crrcd to Nunclon IO-ml tirrucculturc boltlcs. TCM wuschungcd 
every 4 or 5 days. Cell viability of infected und conrrol cultures WIS 
periodically errcrscd by Trypn blue exclusion, 
Staurosporinc was obtnind from Sigmu (9. Louis. MO. USA). 
Stock stuurosporinc w~ls diluted in DMSO, Target cells wcrc prc- 
incubutd with either 70 nM (HUT-78 nnd HSB: cells) or 150 nM 
(LDV17 calls) of slaurosporinc for six days prior IO HIV inkction. 
Virul infection and further incubation of troatod culiurcs Wcrc carried 
out in prcssncc of stnurosporine rl rhe abovc.msntioncd conccmrn- 
lions. The linlri DMSO conccntrulion in stnurorporinc-trcnud cul- 
lures \YiIs SO,l%. This cmiccnlmtion of DMSO bus 110 CITCC~ 011 HIV 
rcplicntion and production by infcctcd ccllr [ 1 I], 
170 
Yolumc 308, number ? FEES LE7TERS Augusl 1992 
2.3. Virus litrthn 
CclCfrcc Rltrrcd supcrn;ttlrntr rom HIV-1 infected cul:urer were 
cnllrc~cd irnd p24 concentrations wcrc dclcrmincd by ELISA, The 
rupcmutrrnrr wcrc funlw diluted with RDMI-I640 medium ~oobtnin 
cqu1~I p24 concentrations in smurosporinc~rrcatcd rind non*trcutcd 
samples. Scriill lO.fold dilutions from mch suprnutunt wcrc mudc in 
RPMI.1640 medium. 
Aliquar of each dilution (I ml) wcrc added to sumplcs of rrcsh 
LDW7 cells (ubou~ 1x10’ cdlr in I ml of KM without swum). The 
virus was allowed to adsorb rt 37% Ibr I h. then rhc unadsorbsd virus 
wtls removed by washing the cells in PBS. tind the linul cell pcllcts wcrc 
rcsuspsndcd in fresh TCM. fich sample was cqurlly divided into four 
wells of n COSTAR Clustc?’ tray (2 mUwell). The culturcr wcfc 
incuburcd at 37% in 5% C& On dry 9 pi.. 0.5 ml rrliquotr from cacb 
well were collcc~cd to dctcrminc the prcscncc of progeny virus by 
mururing the amounts ofpl4 (duplicates from arch snmplc). KID& 
ml WIJ cslimutcd by the method of Rcrcd and Mucnch [I?]. 
The prccntrgs of HLV-infcctcd cells wns dctcrmincd by indirect IF 
using B Mnb specific for ~24 [I 11, 
DNA was labcllcd by incubutiny cell cultures with mclhyl- 
[V!!lhymidinc dilukd in RPM14640 medium, Cullum wcrc labcllcd 
nr $05 &i/ml, Triplicate nliquots (2 ml) wcrc collrclcd avcry 24 h and 
trcscd with 5% trichloroxctic ucid. The ucidprccipitablc r;rdio;lctiv. 
ity was collcctcd anlo glass-fibrc lilterr (Whrtmun). which H’CW fur. 
thcr washed with cthunot und dirtillcd wntcr. The mdioactivity in the 
dried filters wus counted in II rolucnc-based liquid vintilhmt. 
3. RESULTS 
A 72-h prc-incubation with staurosporinc prevented 
the cells of the three ce!l lines from entering S pltilsc and 
from further cell division, 3s established by the abscncc 
of [‘Hlthymidinc incorporation into cellular DNA over 
o period of 7 deys following rhc addition of lubcllcd 
thymidinc(Fig. 1) and the luck of further incrcusc in cell 
numbsrs in stuurosporinc-treated cultures (Tuble I). 
However, nll three cell lines studied wcrc productively 
infected by HIV-1 in spite of conti;luous incubutian 
Table I 
El&t of s!uurobporinc on cell proliferation us cstablirhcd by ccl1 
counting 
Cell lint Slauro. cellrlml 
sporinc (nM) 
-- 
Duy 0 Dny 9 
&lUT-?lr 
HUT-78 - 
3.4x10’ (88) 2.Sx10° (82) 
70nM .?.AxlO’ (88) 3.7x10’ (79) 
HSB: 42x10 (95) 4,4x10’ (87) 
HSB: 7OnM 4,kW (95) 2.7x10’ (88) 
LDYI7 2.9x10s (92) 4,6x10* (89) 
tDVI7 15&M 2.9~ la’ (92) 2.3~10’ (86) 
HUT-76, HSB, and LDVI7 cultures were set upot the indicutcd inhial 
ccli dcnsitics. Direct cell counts wcrc atablishsd cvcry other day uting 
o hncrnocytomctcr. The numbcrr in brackets rcprcscnt rhc pcrccr:lapc 
of viable cells in cncb culture on the given dates, Ccl1 viubility was 
crtablirhcc! by Trypnn blue exclusion counting 3W cells. 
with nr\urosporinc prior, during, and after the viral 
infcetion: ~24 was rcudily dcccctcd in supsrnntunts from 
stnurosporinc-trcutcd ultures (Table II). At lcnst some 
if not ull such ~24 corresponds to fully infcctiaus I-W-1 
(Tublc III). whilst the titers of infectious viru!; present 
in stock suspensions contuining equal concentrations of
~24 from cichcr control or sttrurosporinc-trcsrcsd ul-
tures arc very much the same (Table LV). Indirect im- 
munofilrorcsccncc, using u monoclonel antibody sgc- 
cific for ~24. also showed that the pcrcentagf. of p24* 
cells is quite similar in control and staurceporinc- 
trcutcd cultures (Tublc IV). 
Since LDV17 is u cctl line able to sustain lung-term 
continuous production of HIV-1 without undergoing 
cytopathic effects [I ! 1. it was used CO study the rffcct of 
strrurosporinc on WV-1 production by chronisally in- 
fected cells. Tublc V shows that chcrc is no clear stauro= 
sporinc-induced reduction of HIV-l production when 
compurcd with non-trcutcd control infsctcd cultures. 
LDV# cultures. continuously incubated in prcscncc of 
stuurosporinc. tin sustain HIV- 1 production for more 
thun 70 days. even though chcrc is LL dccrcasc in the 
amount of ~24 shrd into the culture medium after the 
pcuk lcvcl uchicvcd on day 14 pi. (Fig. 3, It is worth 
noting that after cuch time-point dctcrmination, the 
TCM was chnngcd by pelleting and washing the cells. 
Thcrcforc. the ~24 dctcctcd in each further sumplc is 
produced anew. 
4. DISCUSSION 
It is widely usccptcd that only activnccd lymphocytes 
can bc productively infected by HIV-I [Z-4]. It is also 
Teblc II 
R&nsc of ~24 b!, :hm human cell liner in prcscnsc or st;lurosporinc 
Cell line Stuuro. ~24 (ng’ml) Ccl1 viability (%) 
rporinc (nM) 
i1 b il b 
HUT-78 - 0.95 0,74 78 t2 
HUT.78 70 0.64 027 74 87 
HSB: . . 0.05 OX09 88 I 67 
CISB: 70 a.02 0.66 89 73 
LDVI7 0.42 0.62 82 78 
LDVl7 I50 0.06 0.73 90 86 
The data arc from IWO scpuratc cxpcrimcnts (it and b). Ywrosporinc- 
cantniningculturcs wcrc prc-incubated with the antibiotic bdays prior 
to HIV inrcction, HIY infection und a further 8~ (Exp~. a) or l2-d~~ 
(Expt. b) incubationswcrc cxricd out in lhc prcrncc o~slilurospofinc 
(70 nM for HUT-78 und HSB, cull liner; I50 nM f’or LDV/7 cells). 
CcllXrcc supmutants from control nnd trcatcd culture wcrccallcclcd 
on dny 8 pi. (Enpi, a) or I2 p,i. (Expt, b) and lriplisa~c S~inPlcS were 
uwycd Ibr ~24. The S.D. umony tripliWc% wlili cS%. Ccl1 viabilily 
was cstnblishsd by Trypan blue exclusion caunliny 300 ~~11s. 
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Fig. I, Effect d staurorporinc on long-term [Pi-l]thymidinc inctirpera- 
tion intoccllulnr DNA. MSB:cclls wcrc incubated with 70 nM stuuro- 
rporinc (solid trinnpla) from 72 h bcfon addition of Lnbclkd fhymi- 
dine, nnd kept in prercncc of rtnurosporinc throughout the cxpsri- 
mcnt. A panllcl MSB: non-stnurorporinc-treated culture was the 
[‘WlTdr insorporution control (open triangln). A similar cxprimcnt 
wu performed with LDW cells trcntcd with I50 nM strurasporinc 
(solid circles) und non.trcatcd LDVI7 cells (solid qunrcs). Triplicutc 
samples from each culture were proccsscd on lhc given days. The S.D. 
itmong tripliwtw was *l?%k. 
known that the life cycle of most rctroviruses requires 
the growth and division of the host-ceil in or&r to 
nchicvc stable intcgmcion of the viral gcnomc into the 
host-ccl1 DNA [1]. HOWCW, it has been reported that 
rcrroviruscs of the icntivirus class. to which HIV-1 bc= 
longs, can stably replicate in non-dividing cells without 
the need for integration [i3], and fur~hcrmorc, that 
E-W-1 intcgrasc-deletion mutants can reedify infect T- 
lymphocytes, thus giving origin to cxtrachromosomal 
Table III 
Assay of infectivity of cell-free su~mrtuntr from staurospnrinc- 
trcxcd ond non-trcatcd HWI-infcctcd cultures 
Supsrnatnnts from ~24 fn@ml) in newly infected 
LDW culturcr 
al b 
-_ 
HSl32 0.065 0.042 
H5BI + staurorporinr (70 nm) 0.062 0.037 
LDYi7 0.880 0.470 
LDV/7 + etaurosporinc (I 50 nM) 0.760 0.540 
Cell-frcr supcrnutants from rluurosporinc-trcatcd und non-trcatcd 
HIV-1.infcctcdculturcs wcrccollcctcdondny 12p.i. and used toinfcct 
frssh LDW cells. Presence of progeny virus in the newly-infcctcd 
cultures was dctcrminrd on day 9 pi, by assaying the amount of ~24 
present in tissue culture supcrnutanlr (triplicates); a and b iodicatc 
datu from t:vo separate cxperimcnts. 
a0 40 09 00 
dorr P.t. 
Fig. 2. Effect ofcontinuous Incubation in rtaurosporinc on lon~tcrm 
HIV-I production by LDV/7-infcctcd cultures. LDW7ccllr wcrc incu- 
butcd with IS0 nM rtnurosporinc from day 6 kforc HIV infection 
onwards @lid trienglcr). A parrllcl non-staurospxinc-trcatcd LDW 
culture was infcctcd on the snmc dny (solid circks). Prcssncc of p24 
antigen in wmplcr (triplicutcs) of cell culture supern~tants was htcr- 
mined on tks indisxtcd dnys post.infcrtion. The SD, among triplicates 
was 55%. The ccl1 density on the dry of infection wus lxlOccclls/ml 
for both control und rtnurosporinc-treated culturcr. The control cul- 
turc kept growing and dividing throughout the cxprimcnt. The cell 
density was continuously adjusted to keep it near the originui value. 
In the stuurorporinc.trcatcd culture, thcccll density was continuously 
reduced by the luck of further ccl1 division coupled with ccl1 losses after 
crch change of ‘KM. The ccl! dcnsily on drty 70 pi. was 1.3SxIO’ 
c&/ml for the infection cantrol und 9x10’ ccllr/ml for the stuuro- 
sporinc-treated culture. The cell vhbllity was 84% in the infection- 
control and 76% in the rtuurosporlnc-trcntcd culture. 
forms of HIV-1 DNA which are tronscriptionaily as- 
tivc, as manifcsrcd by production of p24 antigen into rhc 
culture mcdiurn. It MI, however, not possible to rescue 
infectious virus from cutturcs infected with such intc- 
grasc-deletion mutants 141. 
In the precnt study it is shown that staurosporinc- 
blocked ceils cun produce newly-synthesized ~24, aald 
that some, if not all, of this ~24 represents infectious 
HIV-I. The fact that staurosporinc-lrcated LDV/7 cells 
can continuously produce HIV-I for more than 70 days 
(Fig. 2) sugEwts that the viral DNA is in stable form 
within the staurosporinc-treated cells. This seems con- 
sistent with recent observations which show that HIV-: 
can productively infect and intqmtc its genomc in rcst- 
ing monocylcs [14]. 
The amount of ~24 present in supcrnatants frc;m 
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Table IV 
Pcrccntnyc of HIV.infectcd cells art3 titer ofinlklious virus in wuro- 
sporincmud and non.tnxed HIV-I~infcclcd culturcr 
Ccl1 IInc Stauro. 
r;porinc 
(aM) 
~24’ cells Ceil viability Virus titer 
(a) (ap) CTCIDdml) 
HUT-7&l 41 78 lo*?’ 
HlJT.‘)r;( 70 35 74 IOhm 
USD: . . 31 88 ND. 
HSB: 70 27 89 N.D. 
LDvn 14 7% I en 
uwn I50 I2 86 IV% 
The percentage of ~24’ cells wcrc determined hy IF using an anti-p24 
Meb. 300 &Is wcrc ccluntcd per siunpl:. 1F wus dctcrmincd on days: 
&I pi. for HUT.78:9 p.i. for HSB:: I3 p-i. for LDVI1. Cell viability was 
cstablishcd by Tryptrn blue cxclurion counting 300 ccllr. Far virus 
titration. ccll~frcc filtered ruprnutnnla from stourorporinc.trcntcd 
und non#culcd HIV-inl’cctcd HUT-78 and LDV/7 cultures wcrc ad- 
justed td the Itlmc p24conccnlrntion (OS06 nglml), then rcrinl tcn.fold 
dilutions wcrc urcd to infect fresh LDVi7 cells (quadruylicatcr). Prca- 
cncc of proucny virus was dctcrminsd on duy 9 pi., using n p24- 
rpecitic ELfSA. TC:lD&ml was cstimulcd by the mcrhod of Reed and 
Mucnrh [ 1 I]. ND.: not done. 
staurosporinc-trcutcd ells is consistently smaller than 
that present in supcmotants from non-treated cultures. 
I-iowcvcr, our results suggest hat the infectious-virus 
yield per cell is rather similar, 11s hown by the titration 
experiments, for control and stnurosporinc-treated cul- 
tures. Thus, the difference in p24/ml of supcrnatnnt ob- 
served between treated and non-treated sultures seems 
to bc due to the diffcrsncc in absolute ccl1 numbers. 
following the arrest in cell division caused by continu- 
ous treutmsnt with sttiurosporins, while in the infected 
control cultures the cells keep growing and dividing 
throughout he experiment. 
It has been reported that binding of HIV-1 to CD4 
Table V 
Effect of stuurorporinc nn ‘Hi’;-1 production by chronically infected 
LDvn cclll 
p24 (n@ml) 
Days post-treatment In prcscnlr of In absence of 
stnurospurinc staurosporinc 
0 1 so I .36 
7 1.25 0.42 
15 0.80 O,M 
LDV,7 cu::urcs inftctcd u,ith HIV.1 for 29 drays were tranafcrrcd to 
fresh TCM with (150 nM) or without staurosporinc and funhcr incu- 
bated for 15 days. The amounts of p24 in ccll.frcc supcrnatants (trip- 
licaicr) wcrc dctcrmlncd on the indicated days post.trcntmrnt. The 
X,il. iirnona trlpllcatcr was 55% 
receptor induces a protein kinasc C-mediated phospho- 
rylotion of the receptor end that this phosphocylation 
is inhibited by the protein kinas-c C inhibitor H-7, thus 
resulting in accumulation of virus particles at the cell 
surface and subsequent inhibition of HIV infectivity [61. 
Howcvcr. other laboratories have failed to detect any 
changes in CD4 phosphoryltition after binding of HIV 
or purified viral envelope protein gpl20 [ 15) Moreover, 
rccsnt studies indicate that P component of the T cell 
receptor-CD3-Jcprndcnt phosphorylation of CD4 is 
not mcdintcd by protein kinass C. and that infEction 
with HIV-l inhibits the activation of protein kinase 
associated with the T ccl1 receptor-CD3 cornplcls by a 
mechanism which is indcpsndcnt of viral cnv:lopc pro- 
teins [ 151. However, diffcrcnccs between the effects of 
H-7 and staurosporinc upon cellular protein kinoscs 
have been consistently reported in the literature [l&18], 
and it is now well established that many statlrosporine 
effects on ccl1 tnctirbolism urc not due to protein kinasc 
C inhibition [8,9, IS]. 
The fact that stuurosporinc, a general protein kinasc 
inhibitor, is unable to inhibit HIV-l infcstivity suggests 
that the protein kintlscs rcspcstivcly targeted by H-7 
and staurosporinc arc of a different nature and have Q 
different influcncc in the life cycle of different viruses. 
Sttlurosporinc seems to selectively inhibit a ~34~“‘~ ki- 
nasc-dcpcndsnt mechanism that regulates the onset of 
ccllultlr mitosis [8,9]. Consequently, one may infer that 
such o mechanism is not crucial for the life cycle of 
HIV-I. 
The prcscnt results show that blocked non-cycling T 
cells can be productively infected by HIV-l. This sug- 
gests that under certain circumstancca, HIV-1 can be 
found in a stable and active state in resting T cells. It 
remains to bc established whether this fact may bs rclc- 
vant to the pathogen& of AIDS. 
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